Inventor
WANG ANLAI
US36 patents
⚠️ This page may combine multiple inventors who share the name “WANG ANLAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
32 patentsUS10934288B2Mar 2, 2021
Pyrazolopyridine compounds and uses thereof
INCYTE CORP13 citations94
US10435405B2Oct 8, 2019
Pyrazolopyridine compounds and uses thereof
INCYTE CORP23 citations94
US10266530B2Apr 23, 2019
Pyrazolopyridine compounds and uses thereof
INCYTE CORP24 citations94
US9278950B2Mar 8, 2016
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
INCYTE CORP24 citations94
US9676750B2Jun 13, 2017
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
INCYTE CORP18 citations93
US9540347B2Jan 10, 2017
Pyridineamine compounds useful as Pim kinase inhibitors
INCYTE CORP19 citations93
US9580418B2Feb 28, 2017
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
INCYTE CORP19 citations92
US9556197B2Jan 31, 2017
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
INCYTE CORP19 citations92
US11492354B2Nov 8, 2022
Indazole compounds and uses thereof
INCYTE CORP8 citations86
US10752635B2Aug 25, 2020
Indazole compounds and uses thereof
INCYTE CORP16 citations86
US11607416B2Mar 21, 2023
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP7 citations85
US10450296B2Oct 22, 2019
Heterocyclic compounds useful as Pim kinase inhibitors
INCYTE CORP6 citations84
US10000507B2Jun 19, 2018
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
INCYTE CORP12 citations84
US9920032B2Mar 20, 2018
Heterocyclic compounds useful as pim kinase inhibitors
INCYTE CORP12 citations84
US7511050B2Mar 31, 2009
Purinone derivatives as HM74A agonists
INCYTE CORP14 citations84
US7576089B2Aug 18, 2009
3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
INCYTE CORP8 citations83
US12384778B2Aug 12, 2025
Pyrazolopyridine compounds and uses thereof
INCYTE CORP1 citations75
US7678798B2Mar 16, 2010
Piperazinylpiperidine derivatives as chemokine receptor antagonists
INCYTE CORP5 citations74
US7462624B2Dec 9, 2008
Purinone derivatives as HM74a agonists
INCYTE CORP8 citations74
US11795166B2Oct 24, 2023
Pyrazolopyridine compounds and uses thereof
INCYTE CORP2 citations73
US11229631B2Jan 25, 2022
Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors
INCYTE CORP0 citations63
US11053215B2Jul 6, 2021
Heterocyclic compounds useful as Pim kinase inhibitors
INCYTE CORP1 citations63
US7902205B2Mar 8, 2011
Purinone derivatives as HM74A agonists
INCYTE CORP3 citations63
US12441731B2Oct 14, 2025
Pyrazolopyrimidine compounds and uses thereof
INCYTE CORP0 citations62
US12083124B2Sep 10, 2024
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP1 citations62
US11111247B2Sep 7, 2021
Pyrazolopyrimidine compounds and uses thereof
INCYTE CORP1 citations62
US11591329B2Feb 28, 2023
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP0 citations52
US9890162B2Feb 13, 2018
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
INCYTE CORP0 citations52
US9067921B2Jun 30, 2015
Piperazinylpiperidine derivatives as chemokine receptor antagonists
INCYTE CORP0 citations52
US8039478B2Oct 18, 2011
Purinone derivatives as HM74A agonists
INCYTE CORP1 citations52
US7863285B2Jan 4, 2011
Purinone derivatives as HM74A agonists
INCYTE CORP1 citations52
US8895571B2Nov 25, 2014
Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
INCYTE CORP0 citations38
XUE CHU-BIAO
3 patentsUS8268826B2Sep 18, 2012
Piperazinylpiperidine derivatives as chemokine receptor antagonists
XUE CHU-BIAO3 citations61
US8680104B2Mar 25, 2014
Piperazinylpiperidine derivatives as chemokine receptor antagonists
XUE CHU-BIAO0 citations51
US8697870B2Apr 15, 2014
3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
XUE CHU-BIAO0 citations50